Profile image
By Michael Johnston (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

BioShares and Reality Shares Make Their Debut; ValueShares Launches IVAL

Monday, March 20, 2017 7:57
% of readers think this story is Fact. Add your two cents.

This week in ETFs, two new issuers made their debut: BioShares by LifeSci Index Partners and Reality Shares. The two new BioShares funds offer investors a compelling way to make a more targeted play on the fast-growing biotechnology sector. Reality Shares’ new actively-managed ETF provides a new twist on dividend investing, focusing more on the expected growth of dividends instead of yield. Also this week, ValueShares launched the international version of its “quantitative value” fund [see also ETF Spotlight: MSCI USA Size Factor ETF (SIZE)]. More Granular Biotech Exposure On Tuesday, BioShares by LifeSci Index Partners launched two new funds that are aimed at providing investors unique exposure to the biotechnology industry. The BioShares Biotechnology Products Fund (BBP) tracks the LifeSci Biotechnology Products Index, an equal weighted benchmark that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration […]

Click here to read the original article on

Related Posts:

  • No Related Posts


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.